Polarean Drug Patent Portfolio

Polarean owns 1 orange book drug protected by 2 US patents Given below is the list of Polarean's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11052161 Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices 29 Dec, 2035
Active
US10583205 Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices 20 Feb, 2035
Active


Given below is the list of recent legal activities going on the following drug patents of Polarean.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 23 Aug, 2023 US10583205
Post Issue Communication - Certificate of Correction 09 Nov, 2021 US11052161
Email Notification 04 Nov, 2021 US11052161
Mail Certificate of Correction Memo 03 Nov, 2021 US11052161
Certificate of Correction Memo 01 Nov, 2021 US11052161
Recordation of Patent Grant Mailed 06 Jul, 2021 US11052161
Patent Issue Date Used in PTA Calculation 06 Jul, 2021 US11052161
Email Notification 17 Jun, 2021 US11052161
Issue Notification Mailed 16 Jun, 2021 US11052161
Dispatch to FDC 01 Jun, 2021 US11052161
Application Is Considered Ready for Issue 28 May, 2021 US11052161
Issue Fee Payment Verified 27 May, 2021 US11052161
Issue Fee Payment Received 27 May, 2021 US11052161
Mail Post Card 01 Apr, 2021 US11052161
Email Notification 24 Mar, 2021 US11052161


Polarean's Family Patents

Polarean drugs have patent protection in a total of 6 countries. It has a significant patent presence in the US with 58.3% of its patents being US patents. Click below to unlock the full patent family tree.

Family Patents



Polarean Drug List

Given below is the complete list of Polarean's drugs and the patents protecting them.


1. Xenoview

Xenoview is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11052161 Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices 29 Dec, 2035
(11 years from now)
Active
US10583205 Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices 20 Feb, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xenoview's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List